Product Information
COPAXONE 40 MG/ML SYRINGE is a brand product labeled by Teva Neuroscience, Inc., priced at $541.0738 per ML under NDC 68546032512. Its NADAC has been published 623 times since Jul 23, 2014.
The High Outlier badge above means this manufacturer's average price in the Glatiramer Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Teva Neuroscience, Inc.NDC
68546032512
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020622On Market Since
1/29/2014
Price Statistics
The NADAC for COPAXONE 40 MG/ML SYRINGE has been published 623 times since Jul 23, 2014, and over the history we have for it it has risen 45.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $541.0738 per ML |
|---|---|
| All-time high | $541.7390 (May 13, 2026) |
| All-time low | $371.9568 (Jul 23, 2014) |
| 52-week high | $541.7390 |
| 52-week low | $495.1664 |
| Median price | $471.3680 |
| Average price | $462.6861 |
| Largest weekly change | +9.4% (Jan 7, 2026) |
| Weeks tracked | 623 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of COPAXONE 40 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for COPAXONE 40 MG/ML SYRINGE, manufactured by Teva Neuroscience, Inc., is $541.0738 per ML (NDC 68546032512), effective Jun 24, 2026.
How has the price of COPAXONE 40 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for COPAXONE 40 MG/ML SYRINGE has risen 45.5%. It has been tracked across 623 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for COPAXONE 40 MG/ML SYRINGE?
Since Jul 23, 2014, the NADAC for COPAXONE 40 MG/ML SYRINGE has ranged from a low of $371.9568 (Jul 23, 2014) to a high of $541.7390 (May 13, 2026), with a median of $471.3680 per ML.
Are there cheaper alternatives to COPAXONE 40 MG/ML SYRINGE?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GLATOPA 40 MG/ML SYRINGE, is $95.4165 per ML — about 82% below COPAXONE 40 MG/ML SYRINGE.
Who manufactures COPAXONE 40 MG/ML SYRINGE?
COPAXONE 40 MG/ML SYRINGE (NDC 68546032512) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification